PharVision Advisers’s FMC FMC Stock Holding History

PharVision Advisers’s Portfolio FMC Stock Details FMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,043	Closed	-$294K	–	354
2024 Q4	$294K	Buy	+6,043	New	+$353K	0.25%	165

Other funds holding FMC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's FMC Position: Q1 2025 in Review

PharVision Advisers sold out of FMC (FMC) in Q1 2025, closing a stake of 6,043 shares — an estimated $294K sold.

PharVision Advisers first reported a position in FMC in Q4 2024 and held it in 1 quarter. The position peaked at $294K in Q4 2024. 530 funds tracked by Wall St. Rank hold FMC as of Q1 2025.

PharVision Advisers reported no remaining FMC position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 6,043 FMC shares in Q1 2025, an estimated $294K.
PharVision Advisers first reported a position in FMC in Q4 2024 and held it in 1 quarter.
PharVision Advisers's FMC position peaked at $294K in Q4 2024.
530 funds tracked by Wall St. Rank held FMC as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.